Alfons Schnitzler
Alfons Schnitzler is an expert in Neurology at Heinrich Heine University Düsseldorf (Germany). As of October 2026, ScienceLeadR ranks Alfons Schnitzler in the top 1% of experts worldwide for Electric Stimulation Therapy, Basal Ganglia Diseases and Parkinson Disease. Alfons Schnitzler has authored 693 publications, the most recent in 2026, and is an investigator in 18 clinical trials, 2 of them ongoing. SLR score: 2,082 (community average: 125). How the SLR is computed.
LeadR Profile
Neurology
Subspecialties: Public Health - Surgery - Medical Imaging
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1992 - 2026
Number : 693
Citations
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Reply: Is the high beta response network orthogonal to subthalamic topography? PMID 42834005 | Brain | 2026 | 0 |
| Dopamine modulation of motor and implicit learning contributions to auditory temporal attention. PMID 42774941 — dopamine, learning | iScience | 2026 | 0 |
| Phenotype-specific white matter microstructural alterations and their clinical correlates in Wilson disease. PMID 42562855 — white matter, neurites, phenotype, hepatolenticular degeneration | Sci Rep | 2026 | 1 |
| PSP-specific atrophy targets regions connecting the salience network and subcortical circuits. PMID 42462481 — gray matter, atrophy, brain, cholinergic agents | Neuroimage Clin | 2026 | 0 |
| Planimetric and Linear MRI Markers for Progressive Supranuclear Palsy Classification: A Large Multicohort International Study. PMID 42227858 — supranuclear palsy, progressive, parkinson disease, parkinsonian disorders, classification, mesencephalon, radiology, diagnosis, paralysis | Radiology | 2026 | 0 |
Clinical Studies 18
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 4
Ongoing Clinical Trials
2 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Safety Tolerability and Symptomatic Efficacy of the ROCK Inhibitor Fasudil in Patients with Parkinson s Disease (ROCK PD) 2024-517413-33-00 — safety, parkinson disease | Phase 2 | Active not recruiting | 2023 |
| Chronic Outcome Monitoring for DBS in Dystonia NCT07244549 — electrophysiology, brain, dystonia, biomarkers, signs and symptoms, deep brain stimulation, records, therapeutics | N/A | Recruiting | 2024 |
LeadR Networks
Main global connection map